Celgene joins the PD-1 checkpoint club, bagging BeiGene drug with $413M down and $1B on the table
Celgene is joining the fast growing PD-1 club.
The big biotech $CELG has taken a lead position in the second wave of PD-1 checkpoints in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
